Exploring ICP-MS expertise at Almac
A discussion about Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and its importance within drug development.
APIs
- All
- APIs
- Aseptic Processing
- cGMP Manufacture
- Cleaning Validation
- Clinical Trial Materials
- Cytotoxics and High Potency Manufacturing
- Excipients
- Extractables and Leachables
- Facilities
- Fill/Finish
- Lyophilization
- Parenterals
- Process Development
- Process Validation
- Risk Management
- Scale-up/Technology Transfer
- Solid Dosage/Creams/Ointments
-
APIs | QA/QC | Validation
Microbiological Testing Considerations for Pharmaceutical Products
Microbiological testing is a critical component to ensuring the quality and safety of pharmaceutical products. Explore more in this webinar on August 26.07.26.21
-
APIs | Breaking News | cGMP Manufacture | Industry News
MediPharm Labs Receives Canadian GMP Pharmaceutical DEL
License can be used for manufacturing, testing and sale of APIs and pharmaceutical drug products containing cannabis.07.15.21
-
APIs | Cytotoxics and High Potency Manufacturing | Drug Development
Leverage the Benefits of Biocatalysis with the Right API CDMO
A powerful tool for organic synthesis, enzymatic chemistry has become an established methodology for manufacturing APIs.
-
APIs | Breaking News | GMPs/GCPs | Industry News | QA/QC
Purisys Obtains Two Global ISO Certifications
Now certified for ISO 17025 for Testing and Calibration Laboratories and ISO 17034 for Reference Material Producers.07.08.21
-
APIs | Formulation Development
Shaping the Future of Formulation Development with Melt-based 3D Printing Technologies
In this white paper, the use of 3D printing is explored, with a focus on enhancement of bioavailability of APIs in solid dispersions.
-
APIs | Breaking News | Facilities | Industry News
Almac Expands Crystallization Capabilities
A new Empyrean X-ray powder diffractometer is part of the investment.07.01.21
-
APIs | Breaking News | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Industry News
Lonza Expands API Development, Mfg. Facility in China
20M CHF investment will include three 1,000L GMP trains and new development and GMP labs with HPAPI capabilities.06.28.21
-
APIs | Drug Development | Formulation Development
QBD Addresses API Supply in Orphan Drug Formulation
Due to the high costs and low demands of the drug product, it is important to efficiently use API supply during the formulation process.
-
APIs | Breaking News | Facilities | Industry News
Novasep Upgrades API Manufacturing Facility
A $7.3 million investment will be made over 3 years to modernize the Mourenx site.06.25.21
-
APIs | Supply Chain
Maintaining Critical Drug Supply During the Pandemic
Vin Colicchio from Dr. Reddy’s talks about the challenges and solutions of maintaining supply during the pandemic.Online Exclusives Tim Wright, Editor, Contract Pharma 06.17.21
-
APIs | Drug Development
Biocatalysis: An Indispensable Tool for API Synthesis
Biocatalytic processing offers a wealth of advantages and should be evaluated during early-stage drug development.Benzion Dolitzky, VP R&D, Wavelength Pharmaceuticals 06.07.21
-
APIs | Breaking News | cGMP Manufacture | Industry News
Onyx Scientific Receives Commercial API License for UK Facility
Allows Onyx to support API projects from pre-clinical studies to low volume commercial manufacture.Charles Sternberg, Assistant Editor 06.03.21
-
APIs | Cytotoxics and High Potency Manufacturing | Formulation Development | Process Development
Solubility Enhancement of Hydrophobic Drugs and APIs Using Hot Melt Extrusion
Efficient processing and production technology for solid molecular dispersion, HME can provide sustained, modified and targeted drug delivery.Ameya Deshpande, Formulation Scientist, Avomeen 05.25.21
-
APIs | Breaking News | Collaborations & Alliances | Cytotoxics and High Potency Manufacturing | Industry News
FDA Approves ADC Therapeutics' Zynlonta
ADC collaborated with CDMO Sterling Pharma Solutions to develop the cancer drug.Tim Wright, Editor, Contract Pharma 05.07.21
-
APIs | Capsules | Formulation Development
How to Achieve Precise and Flexible Dosing with Multiparticulates
Multiparticulate systems have several advantages over conventional tablet or capsule formulations. Download this whitepaper to learn more.
-
APIs | Drug Development | Process Validation
-
APIs | Supply Chain
Securing Your API Supply Chain: Three Keys to Success
Key considerations when outsourcing API procurement and supply chain management.Selwyn Lustman and Lina Cogan, LGM Pharma 04.01.21
-
Analytical Services | APIs | cGMP Manufacture | Excipients | Formulation Development | QA/QC | R&D | Solid Dosage/Semi-solids
Enteris BioPharma: Custom Solutions – From Bench to Market
CDMO operations are housed within a 32,000-square-foot, FDA-inspected and cGMP-compliant facility in northern New Jersey.
-
APIs | Breaking News | cGMP Manufacture | Industry News
Piramal Pharma to Acquire Indian API Manufacturer Hemmo
Adds peptide API development and manufacturing capabilities for growing number of oncology and metabolic therapies.Kristin Brooks 04.01.21
-
APIs | Breaking News | Custom Sourcing News
Asymchem Expands Oligonucleotides Mfg. Capacity
API facility in Tianjin, China will accommodate gram to ton production scales with capacity to accommodate 12 or more oligo process production lines.Kristin Brooks 03.26.21
